Although the prevalence and incidence of dry eye disease (DED) varies widely due to a lack of standardized testing and criteria, a recent report estimates more than 16 million adults in the U.S. are diagnosed with DED. Dry eye accounts for almost 25 percent of medical eyecare visits and has been estimated to cost the U.S. health care system $3.84 billion annually—this number increases to $55.4 billion when considering societal costs. While optometrists are fortunate to have an expanding armamentarium, artificial tears remain an integral part of the basic management strategy as a recommended first-line option. When it comes to dry eye disease, find out how to steer your patients in the right direction in this feature from Review of Optometry. Read More.